Vibrasense Shark Tank India Episode Review
Website Information
- Website:- Vibrasense
- Build on CMS WordPress
- Poor SEO Performance, SEO improvement is needed.
- ORGANIC TRAFFIC: 0 visitors per month.
Founders
- Vibrasense was founded in 2019 by Nishant Kathpal, who is passionate about using technology to improve healthcare outcomes.
Brand Overview
- Vibrasense, developed by Ayati Devices, is a healthcare startup focused on detecting neuropathy and foot complications caused by diabetes.
- The company is headquartered in Bengaluru, Karnataka, and specializes in medical devices, diabetes care, neuropathy detection, and diabetic foot screening.
- Vibrasense offers a portable, battery-powered handheld device that quantifies sensation loss in the body within 5 minutes.
- It is a patented, made-in-India product incubated at SINE, IIT Bombay, and has received the BIRAC BIG Grant from the Government of India.
Shark Tank India Appearance and Ask
- Nishant Kathpal appeared on Shark Tank India Season 4, Episode 30, seeking ₹1 crore for 2% equity, valuing Vibrasense at ₹50 crore.
- He showcased their innovative diabetic foot screener designed to help clinicians save time while maintaining diagnostic accuracy.
Season and Episode Air Date
- Season: 04
- Episode: 30
- Episode Air Date: Friday, 14 February 2025
Product Overview
- Vibrasense offers a range of products, including Vibrasense, Vibrasense+T, and Angiocam.
- Their flagship product is a portable, battery-powered handheld device that quantifies sensation loss in the body within 5 minutes.
- It applies a controlled vibration stimulus to the skin to help detect neuropathy at an early stage and can be used to test more than 100 patients on a single charge.
- The device assists neuropathic patients in monitoring their condition for more effective treatment.
- Vibrasense aims to help diabetic patients avoid foot amputation surgeries.
Investor Reactions
- The Shark Tank India Season 4 episode included all Sharks: Kunal Bahl, Peyush Bansal, Anupam Mittal, Namita Thapar, and Vineeta Singh.
- Recognizing the importance of the company’s mission, Sharks Peyush Bansal and Namita Thapar offered a deal of ₹1 crore for 4.76% equity, which Nishant Kathpal accepted.
Customer Engagement Philosophy
- Nishant Kathpal’s dedication to quality, creativity, and customer satisfaction is at the heart of Vibrasense’s success.
Product Highlights
- Portable, battery-powered handheld device.
- Quantifies sensation loss in the body within 5 minutes.
- Can test more than 100 patients on a single charge.
- Helps detect neuropathy at an early stage.
- Aims to help diabetic patients avoid foot amputation surgeries.
Future Vision
- With the investment and mentorship from Namita Thapar and Peyush Bansal, Vibrasense aims to expand its company and further its mission of preventing diabetic foot complications.
Deal Finalized or Not
- Vibrasense secured a deal on Shark Tank India, receiving ₹1 crore for 4.76% equity at a valuation of ₹21 crore.
- The investment was made by Sharks Namita Thapar and Peyush Bansal.
| Category | Details |
|---|
| Website Information |
| Website Name | Vibrasense |
| Build on CMS | WordPress |
| SEO Performance | Poor (Needs improvement) |
| Organic Traffic | 0 visitors per month |
| Founders |
| Founder Name | Nishant Kathpal |
| Year Founded | 2019 |
| Founder’s Passion | Using technology to improve healthcare outcomes |
| Brand Overview |
| Parent Company | Ayati Devices |
| Industry | Healthcare, Medical Devices |
| Focus Area | Neuropathy detection, Diabetic foot screening |
| Headquarters | Bengaluru, Karnataka, India |
| Product Innovation | Portable, battery-powered handheld device for sensation loss detection |
| Key Achievements | Patented, incubated at SINE, IIT Bombay, received BIRAC BIG Grant |
| Shark Tank India Appearance and Ask |
| Season | 04 |
| Episode | 30 |
| Episode Air Date | Friday, 14 February 2025 |
| Investment Ask | ₹1 crore for 2% equity (₹50 crore valuation) |
| Pitch Focus | Diabetic foot screener to help clinicians |
| Product Overview |
| Products Offered | Vibrasense, Vibrasense+T, Angiocam |
| Key Product Feature | Detects neuropathy in 5 minutes |
| Usability | Tests more than 100 patients on a single charge |
| Main Benefit | Helps prevent diabetic foot amputations |
| Investor Reactions |
| Sharks Present | Kunal Bahl, Peyush Bansal, Anupam Mittal, Namita Thapar, Vineeta Singh |
| Final Deal | ₹1 crore for 4.76% equity (₹21 crore valuation) |
| Investors | Peyush Bansal, Namita Thapar |
| Customer Engagement Philosophy |
| Core Values | Quality, creativity, customer satisfaction |
| Future Vision |
| Expansion Plans | Scale operations with investor mentorship |
| Mission | Prevent diabetic foot complications |
| Business Potential in India |
| Indian Healthcare Market Size | $372 billion (by 2022) |
| Diabetes Prevalence | 77 million diabetics in India |
| Total Addressable Market (TAM) |
| Target Market | Diabetic patients in India |
| Neuropathy Risk in Diabetics | 10% (7.7 million potential users) |
| Growth Factors | Increased awareness and monitoring need |
| Ideal Target Audience & Demographics |
| Age Group | 30-65 years |
| Income Level | Middle to upper-middle class |
| Geographic Focus | Urban areas (Mumbai, Delhi, Bangalore, Chennai) |
| Marketing Strategy |
| Digital Marketing | Social media (Facebook, Instagram, LinkedIn) |
| Content Strategy | Blogs, infographics, videos on neuropathy detection |
| SEO Strategy | Improve website rankings to increase organic traffic |
| Webinars & Workshops | Educate healthcare professionals |
| Distribution Strategy |
| Sales Channel | E-Commerce (WordPress website) |
| Healthcare Partnerships | Clinics and hospitals |
| Advantages |
| Key Differentiator | Patented, innovative technology |
| Competitive Edge | Made-in-India product |
| Challenges |
| Market Penetration | Adoption by healthcare providers |
| Competition | Established players in medical devices |
| Reasons for Success |
| Awareness Growth | Rising awareness of diabetes complications |
| Investor Support | Financial and mentorship from investors |
| Mitigation Strategies |
| Customer Feedback | Continuous product improvement |
| Educational Campaigns | Awareness for patients and doctors |
| Future Business Roadmap |
| Short-Term Goals (1 Year) | SEO improvements, urban marketing campaigns |
| Mid-Term Goals (2-3 Years) | Expand diagnostic products, partner with 100+ clinics |
| Long-Term Goals (4-5 Years) | Dominate diabetic care in India, expand to Southeast Asia |
| Valuation Increase Strategies |
| Product Innovation | Improve device features with customer insights |
| Brand Strengthening | Community engagement in diabetic care |
Vibrasense Shark Tank India Business Plan
Business Potential in India
- Market Size: The Indian healthcare market is projected to reach $372 billion by 2022, with a significant focus on medical devices and diagnostics. The diabetic care segment, particularly, is expected to grow as the prevalence of diabetes rises.
- Diabetes Statistics: India has approximately 77 million diabetics, making it the second-largest population of diabetes patients globally. This statistic highlights the urgent need for effective monitoring and treatment solutions like Vibrasense.
Total Addressable Market (TAM)
- Target Segment Size: The total addressable market for Vibrasense includes all diabetic patients in India. If we consider that around 10% of diabetics experience neuropathy, this translates to approximately 7.7 million potential users for Vibrasense’s products.
- Growth Factors: The increasing awareness of diabetic complications and the need for regular monitoring create a growing market for devices like Vibrasense.
Ideal Target Audience and Demographics
- Age Group: Primarily targeting adults aged 30-65 years, who are more likely to be diagnosed with diabetes.
- Income Level: Middle to upper-middle-class individuals who have access to healthcare services and can afford medical devices.
- Geographic Focus: Urban areas where healthcare facilities are more accessible, including cities like Mumbai, Delhi, Bangalore, and Chennai.
Marketing Strategy
- Digital Marketing: Utilize social media platforms (Facebook, Instagram, LinkedIn) to raise awareness about diabetic foot complications and promote Vibrasense as a preventive solution.
- Content Marketing: Create educational content that highlights the importance of early detection of neuropathy and how Vibrasense can help. This can include blog posts, infographics, and videos.
Content and Digital Marketing Strategy
- SEO Improvement: With current organic traffic at 0 visitors per month, a robust SEO strategy is essential. This includes optimizing website content with relevant keywords related to diabetes care and neuropathy detection.
- Webinars and Workshops: Conduct online workshops for healthcare professionals to demonstrate the use of Vibrasense devices and educate them on the importance of early detection.
Distribution Strategy
- E-Commerce Platform: Leverage the existing WordPress website for direct-to-consumer sales, ensuring a seamless user experience.
- Partnerships with Clinics and Hospitals: Collaborate with healthcare providers to integrate Vibrasense devices into their diabetes management programs.
Advantages
- Innovative Technology: Vibrasense’s handheld device offers quick and accurate detection of neuropathy, saving time for clinicians while enhancing patient care.
- Patented Product: Being a patented device developed in India gives Vibrasense a competitive edge in the local market.
Challenges
- Market Penetration: Gaining acceptance among healthcare providers may take time, as they may be accustomed to traditional methods of diagnosis.
- Competition: The medical device market is competitive, with established players already offering similar products.
Reasons for Success
- Growing Awareness: Increasing awareness about diabetes complications creates a favorable environment for innovative solutions like Vibrasense.
- Support from Investors: The backing from investors like Namita Thapar and Peyush Bansal provides not only capital but also mentorship to scale operations effectively.
Mitigation Strategies
- Customer Feedback Mechanism: Implement feedback loops to gather insights from users and healthcare professionals to improve product offerings continuously.
- Educational Campaigns: Launch campaigns aimed at educating both patients and healthcare providers about the benefits of using Vibrasense devices.
Future Business Roadmap
Short-Term Goals (1 Year):
- Improve website SEO to increase organic traffic significantly.
- Launch targeted marketing campaigns focusing on urban diabetic populations.
Mid-Term Goals (2-3 Years):
- Expand product offerings to include additional diagnostic tools related to diabetes management.
- Establish partnerships with at least 100 clinics/hospitals across major cities in India.
Long-Term Goals (4-5 Years):
- Position Vibrasense as a leader in diabetic care technology in India.
- Explore international markets in Southeast Asia where diabetes prevalence is also high.
Valuation Increase Strategies
- Continuously innovate product features based on customer feedback.
- Strengthen brand presence through community engagement initiatives focused on diabetic care awareness.
